All insights
PMS operationsPostmarket evidence cleanupSource review as of 2026-06-08

Unified PMS When Leadership Wants One Cross-Market Operating System

When a quality leader is preparing a multi-market postmarket surveillance review, the problem is that one global workflow can hide which source, owner, and qualified decision belongs to which market. The useful output is a unified evidence map that keeps source facts, owner questions, and qualified-review boundaries visible.

The useful output is a cross-market PMS operating brief with source links, jurisdiction notes, internal evidence threads, owners, and reviewer-owned decisions still open.

For one quality leader before a multi-market postmarket surveillance review.

The cross-market operating moment

Picture the VP Quality in a portfolio governance meeting before adding another market. Each jurisdiction has an artifact, but leadership cannot see one operating rhythm for monitoring, review, escalation, and evidence ownership.

The first move is not to declare whether the signal raises safety, compliance, reportability, equivalence, or exposure questions. The useful move is to map the source streams, local records, owners, and open reviewer decisions.

Unified PMS operating brief

LayerQuestion to answer
Source streamWhich FDA, Health Canada, EU, complaint, CAPA, risk, or service source feeds the workflow?
Record familyWhich PMS, complaint, CAPA, risk, clinical, supplier, or management-review record receives the note?
JurisdictionWhich local requirement or qualified reviewer owns the next decision?
CadenceHow often should the source be checked and who confirms the review?
BoundaryWhich conclusions remain outside the shared operating brief?

What good looks like

The result should be a single PMS workflow map that standardizes source review and escalation while preserving local decision authority.

A useful framework does not claim the system has reached any compliance state. It shows what was checked, where the record lives, who owns the next step, and which questions remain open.

Source ledger

FDA Medical Device Recalls and Early Alerts

What it can tell you

Public FDA recall and early-alert records that can feed a U.S. postmarket monitoring workflow.

What it cannot decide

Whether a company has fulfilled one product's PMS, CAPA, complaint, reporting, or quality-system obligations.

Government of Canada Recalls and Safety Alerts

What it can tell you

Canadian public recall and safety-alert records that may frame Canadian postmarket evidence questions.

What it cannot decide

A manufacturer's, importer owner's, or distributor owner's Canadian postmarket obligations or decisions.

European Commission Medical Devices Sector

What it can tell you

European medical-device sector context that can frame EU postmarket evidence questions.

What it cannot decide

Whether a manufacturer's PMS, PMCF, vigilance, clinical, or conformity evidence is sufficient.

Frequently asked questions

Can one PMS framework replace jurisdiction-specific review?

No. A shared framework can organize sources, records, cadence, and owners. Jurisdiction-specific decisions remain with qualified reviewers.

What is the first useful output?

A unified PMS operating brief with source streams, local record families, owner assignments, cadence, escalation triggers, and open review questions.

Need cross-market PMS sources turned into one operating brief?

Send the markets, source streams, and current evidence map. We can scope a source-backed PMS operating checklist for qualified review.

Reader feedback

Useful pages should feed the next topic choices. Leave a signal or a short comment.

0 approved comments0 awaiting review
Comments are reviewed before they appear publicly. Keep it non-confidential and focused on what helped or what was still unclear.